We read with great interest the paper of Fullerton et al in the March
2007 Pediatrics issue. The authors emphasized the importance of
cerebrovascular imaging in childhood arterial ischemic stroke as a strong
predictor of recurrence(1). They concluded that, notwithstanding its
clinical value, cerebrovascular imaging is not commonly performed but
suggested that “Magnetic resonance angiography is probably a reasonable
first step”.
We are very supportive of this suggestion and would like to highlight
the following: Magnetic resonance angiography (MRA) is non-invasive, does
not involve radiation and can produce high quality vascular images without
contrast, if a flow dependent technique, either a Time-of-Flight (TOF) or
a Phase-Contrast (PC) MRA, is used. Therefore MRA is well suited for this
population.
However MRA has some limitations, such as slow flow saturation and
lack of sensitivity to detect small vessels(2), highlighted by previous
studies. In our experience problematic visualisation of the small
peripheral vessels in most neonatal and pediatric cerebrovascular imaging
studies stems mainly from the use of standard adult protocols and preset
commercially available sequences instead of neonatal and pediatric
dedicated MRA protocols (3, 4).
In our study in a neonatal population we modified the adult preset
sequence into an optimised one that took into account the specific
neonatal anatomic and physiological characteristics: smaller cerebral
vessels, slower blood flow(5) and necessity for fast scans to avoid motion
artefacts. We addressed those characteristics by using higher true spatial
resolution of 0.6x0.6x0.6mm3 to compensate for the smaller vessel size,
multiple overlapping thin slab acquisition to minimise slow flow
saturation and parallel imaging to maintain reasonable scanning times of
approximately 5 minutes helping us achieve motion-free images(6). This
optimised protocol significantly improved peripheral vessel visualisation
both by qualitative and quantitative measures of image quality.
To conclude, we would like to highlight that MRA can be the way
forward in non invasive pediatric and neonatal cerebrovascular imaging to
monitor both disease but also normal vessel development only when it is
used in its full potential; this should involve thorough optimisation of
the MRA protocols based on the anatomical and physiological features of
the target population before embarking on clinical trials.
References
1. Fullerton HJ et al, Pediatrics 2007
2. Busson B et al, Stroke, 2002
3. Kuker W et al, Child’s Nervous System, 2004
4. Allison JW et al, Radiographics, 1994
5. d’Orey C et al, Journal of Perinatal Medicine 1999
6. Malamateniou C et al, Neuroimage, 2006
Conflict of Interest:
None declared